Tools
Stock profile

NOVARTIS AG (NVS)

NVS · Latest close $155.21 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$155.21
As of Nov 18, 2026
Tracked funds holding
11 of 149
2026 Q2 13F filings
Opened / added
0 / 4
vs previous quarter
Trimmed / exited
6
vs previous quarter

NOVARTIS AG (NVS) is held by 11 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 4 funds adding and 6 funds trimming or exiting versus the previous quarter. 0 members of Congress reported 0 purchases vs 1 sale. Latest close $155.21 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Congress
0 buys vs 1 sale
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Bristol (John W. Bristol & Co.) · Harding Loevner · Tweedy Browne — 11 tracked funds hold NVS. See all holders.

Insider and Congress activity

0 members of Congress reported buying (0 purchases vs 1 sale). Politician trading

Often held alongside

MANULIFE FINANCIAL CORP (MFC) · NATIONAL GRID PLC (NGG) · BANCO SANTANDER SA-SPON ADR (SAN) · TELKOM INDONESIA PERSERO-ADR (TLK) · Infosys Ltd (INFY) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Bristol (John W. Bristol & Co.)1.29%557,777TRIMMED (-0.7%) Q3 filed Nov 13
Harding Loevner0.85%578,234TRIMMED (-1.0%) Q3 filed Nov 16
Tweedy Browne0.84%71,125TRIMMED (-0.3%) Q3 filed Nov 4
GQG Partners0.63%2,151,131TRIMMED (-12.1%) Q3 filed Nov 13
Saturna Capital0.60%311,392ADDED (+0.1%) Q3 filed Nov 16
Kahn Brothers Group0.33%13,186TRIMMED (-1.5%) Q3 filed Nov 16
Dodge & Cox Funds0.06%759,373TRIMMED (-89.1%) Q3 filed Nov 13
Maverick Capital0.04%27,789ADDED (+82.3%) Q3 filed Nov 16
Thornburg Investment Management0.01%4,114HELD Q3 filed Nov 13
Mondrian Investment Partners0.01%3,273ADDED (+39.1%) Q3 filed Oct 23

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +3.2% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

168.6293.902024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

182017Q2: 17 funds2017Q3: 17 funds2017Q4: 18 funds2017Q22017Q4

Tracked funds holding this stock, by quarter (2017Q2–2017Q4, 3 quarters). Source: quarterly BEST lists from 13F filings — tracked funds only, not all filers. A stock appears here only if it ever made a quarterly BEST list.

All institutions · Form 13F

Institutions holding1,630 of 8,857 filers
Long-only filers among them1,618
Change vs 2026 Q1+42 net · 1,329 entered · 1,287 exited
Shares reported, all filers135,353,085
Reported value, all filers$21.5B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustryPharmaceutical Preparations (SIC 2834)
Net income · FY2025$14.0B
Total assets · FY2025$110.9B
Shares outstanding1,908,151,679
Market cap (at latest close)$296.2B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Dec 31, 2025.

Short interest

Shares short · Oct 15, 20265,585,310
Share of shares outstanding0.29%
Days to cover3.20

Shares short at recent settlements — Jul 31, 2026: 5.2M · Aug 14, 2026: 5.0M · Aug 31, 2026: 5.6M · Sep 15, 2026: 5.2M · Sep 30, 2026: 5.6M · Oct 15, 2026: 5.6M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Dec 31, 2025.

Fails to deliver

Shares failed to deliver · Oct 14, 202650
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 2026<0.1%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 15K · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 50.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Dec 31, 2025.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Apr 30, 2026Bulto Carulla VictorOfficer6,800$1.0MApr 30, 2026SEC filing
Feb 12, 2026Marshall FionaOfficer30,743$5.0MFeb 12, 2026SEC filing
Feb 9, 2026Bulto Carulla VictorOfficer7,500$1.2MFeb 9, 2026SEC filing
May 23, 2025Marshall FionaOfficer15,000$1.7MMay 23, 2025SEC filing
Apr 30, 2025Kowalski Robert WilliamOfficer1,212$137.3KApr 30, 2025SEC filing
Aug 12, 2024Kowalski Robert WilliamOfficer6,566$733.6KAug 12, 2024SEC filing
May 22, 2024Gal AharonOfficer2,500$254.8KMay 22, 2024SEC filing
Sep 19, 2023Kowalski Robert WilliamOfficer1,581$162.7KSep 19, 2023SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Jul 17, 2025UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCSC 13G139,602,4676.4%Sep 30, 2024SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

0 members of Congress reported buying (0 purchases vs 1 sale).

Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.

Recent activity by member

MemberChamberPartyBuysSellsLatestAmount range
Hern, KevinHouseR01Aug 27, 2026$15,001 - $50,000

Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.

Committee jurisdiction

Industry: Pharmaceutical Preparations (SIC 2834). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 5 Lobbying Disclosure Act filings named this company as client, 2002–2006; most common issues: Health Issues (2), Budget/Appropriations (1), Agriculture (1).

Federal contracts: $50.1M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$7.9M
FY2022$15.2M
FY2023$2.9M
FY2024$24.2M
FY2025$-80.0K
FY2026$0

Largest awards collected

Award IDAgencyAmountStart
HHSD200201561394CDepartment of Health and Human Services$477.4KFeb 6, 2015
36C24921N0367Department of Veterans Affairs$283.6KMar 8, 2021
36C24921N0323Department of Veterans Affairs$283.6KJan 26, 2021
36C24921N0300Department of Veterans Affairs$283.6KJan 12, 2021
36C25721N0069Department of Veterans Affairs$283.5KOct 16, 2020

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Super-investor 13F BEST — appeared in 3 of the last 40 quarterly lists; latest 2017 Q4, ranked #34 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together333.3%-1.8%-2.9%+1.2%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold NVS — ranked by lift, the co-holding pattern described in Methodology: MANULIFE FINANCIAL CORP (MFC) · NATIONAL GRID PLC (NGG) · BANCO SANTANDER SA-SPON ADR (SAN) · TELKOM INDONESIA PERSERO-ADR (TLK) · Infosys Ltd (INFY) · Sanofi (SNY) · NOVO NORDISK A S (NVO) · ALLSTATE CORP (ALL).

Recent 8-K filings

No Form 8-K filings for this ticker in the index (Jan 2023 – present).

Related

MANULIFE FINANCIAL CORP (MFC) · Track Record: how the signals scored · Practice timing on NVS

One email a week: the week’s new filings and research. Subscribe free

← NVR  ·  NVST →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.